Zevin Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Buy
13,737
+644
+5% +$653K 1.75% 25
2025
Q4
$14.1M Buy
13,093
+3,918
+43% +$3.75M 1.89% 23
2025
Q3
$7M Sell
9,175
-2,956
-24% -$2.2M 1.02% 42
2025
Q2
$9.46M Sell
12,131
-404
-3% -$314K 1.36% 35
2025
Q1
$10.4M Buy
+12,535
New +$10.4M 1.64% 30

Other funds holding LLY

Zevin Asset Management's LLY Position: Q1 2026 in Review

Zevin Asset Management increased its Eli Lilly (LLY) stake by 4.9% in Q1 2026, buying an estimated $653K and bringing the position to 13,737 shares worth $12.6M. The position accounts for 1.75% of the portfolio, ranked #25.

Zevin Asset Management first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $14.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Zevin Asset Management held 13,737 shares of Eli Lilly worth $12.6M as of Q1 2026.
  • Zevin Asset Management bought 644 Eli Lilly shares in Q1 2026, an estimated $653K.
  • Eli Lilly made up 1.75% of Zevin Asset Management's portfolio in Q1 2026, its #25 holding.
  • Zevin Asset Management first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • Zevin Asset Management's Eli Lilly position peaked at $14.1M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Zevin Asset Management's 13F filing for Q1 2026, filed 7 May 2026.